MeiraGTx Holdings plc MGTX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
MeiraGTx Holdings plc is a clinical-stage gene therapy company focused on developing novel treatments for serious diseases. The company's primary aim is to harness the transformative potential of gene therapy to address otherwise unmet medical needs. MeiraGTx's pipeline includes programs that target genetic disorders, …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees409
TickerMGTX
Statistics
Market Cap$843.8M
Revenue (TTM)$81.4M
Net Income-$114.2M
Net Margin-140.3%
EPS$-1.48
P/E-6.76
P/S10.45
P/B-13.42
EV/EBITDA-9.37
ROE1971.4%
Dividend Yield—
Price$10.36
Data: Twelve Data · Revenue = mcap / P/S